Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of angiogenic growth factors in breast cancer progression.

× No keyword cloud information.

38 in total

1. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.

Authors: R J Daly; W H Harris; D Y Wang; P D Darbre
Journal: Cell Growth Differ Date: 1991-09

2. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.

Authors: L A Liotta; J Kleinerman; G M Saidel
Journal: Cancer Res Date: 1974-05 Impact factor: 12.701

Review 3. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices.

Authors: R V Iozzo; I R Cohen; S Grässel; A D Murdoch
Journal: Biochem J Date: 1994-09-15 Impact factor: 3.857

4. The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors.

Authors: G Peters; S Brookes; R Smith; M Placzek; C Dickson
Journal: Proc Natl Acad Sci U S A Date: 1989-08 Impact factor: 11.205

5. MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Authors: Y Liu; D el-Ashry; D Chen; I Y Ding; F G Kern
Journal: Breast Cancer Res Treat Date: 1995-05 Impact factor: 4.872

6. Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.

Authors: C L Arteaga; T Carty-Dugger; H L Moses; S D Hurd; J A Pietenpol
Journal: Cell Growth Differ Date: 1993-03

7. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.

Authors: J Adnane; P Gaudray; C A Dionne; G Crumley; M Jaye; J Schlessinger; P Jeanteur; D Birnbaum; C Theillet
Journal: Oncogene Date: 1991-04 Impact factor: 9.867

8. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.

Authors: T Miki; D P Bottaro; T P Fleming; C L Smith; W H Burgess; A M Chan; S A Aaronson
Journal: Proc Natl Acad Sci U S A Date: 1992-01-01 Impact factor: 11.205

9. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

Authors: R J Pietras; J Arboleda; D M Reese; N Wongvipat; M D Pegram; L Ramos; C M Gorman; M G Parker; M X Sliwkowski; D J Slamon
Journal: Oncogene Date: 1995-06-15 Impact factor: 9.867

10. Expression of fibroblast growth factor 1 is lower in breast cancer than in the normal human breast.

Authors: G S Bansal; C Yiangou; R C Coope; J J Gomm; Y A Luqmani; R C Coombes; C L Johnston
Journal: Br J Cancer Date: 1995-12 Impact factor: 7.640

5 in total

1. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.

Authors: E Laughner; P Taghavi; K Chiles; P C Mahon; G L Semenza
Journal: Mol Cell Biol Date: 2001-06 Impact factor: 4.272

The role of angiogenic growth factors in breast cancer progression.